We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+27.07%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$39.1B
AUM Growth
+$5.57B
(+17%)
Cap. Flow
-$1.33B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
25.2%
Holding
834
New
111
Increased
262
Reduced
309
Closed
110
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$2.28B |
| 2 |
Otis Worldwide
OTIS
|
+$193M |
| 3 |
Burlington
BURL
|
+$191M |
| 4 |
AbbVie
ABBV
|
+$178M |
| 5 |
Wayfair
W
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Lockheed Martin
LMT
|
+$339M |
| 3 |
Johnson & Johnson
JNJ
|
+$262M |
| 4 |
Pfizer
PFE
|
+$167M |
| 5 |
Target
TGT
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.52% |
| 2 | Healthcare | 19.78% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Financials | 11.33% |
| 5 | Industrials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
MGM Resorts International
MGM
$11.6B
| $9.83M | 0.03% |
585,100
-9,300
| -2% | -$150K |
|
527
Seagate
STX
$195B
| $9.82M | 0.03% |
202,900
+3,600
| +2% | +$181K |
|
528
United Airlines
UAL
$43.7B
| $9.82M | 0.03% |
283,709
+4,900
| +2% | +$147K |
|
529
Pultegroup
PHM
$25.3B
| $9.81M | 0.03% |
288,300
-4,800
| -2% | -$144K |
|
530
Raymond James Financial
RJF
$34.7B
| $9.79M | 0.03% |
213,450
-3,600
| -2% | -$162K |
|
531
Royal Caribbean
RCL
$87.9B
| $9.57M | 0.02% |
190,200
-3,700
| -2% | -$167K |
|
532
Arista Networks
ANET
$249B
| $9.53M | 0.02% |
725,600
+118,400
| +19% | +$1.6M |
|
533
Exelixis
EXEL
$14.1B
| $9.47M | 0.02% |
+399,000
| New | +$9.25M |
|
534
Henry Schein
HSIC
$10.1B
| $9.43M | 0.02% |
161,500
-2,500
| -2% | -$140K |
|
535
Devon Energy
DVN
$49B
| $9.26M | 0.02% |
816,840
+537,500
| +192% | +$6.13M |
|
536
AstraZeneca
AZN
$253B
| $9.26M | 0.02% |
87,500
-187,500
| -68% | -$19.4M |
|
537
NRG Energy
NRG
$25.1B
| $9.21M | 0.02% |
283,020
-4,700
| -2% | -$155K |
|
538
Williams Companies
WMB
$87.3B
| $8.96M | 0.02% |
470,899
-924,600
| -66% | -$17.2M |
|
|
RWT
539
Redwood Trust
RWT
$570M
| $8.75M | 0.02% |
1,250,565
-249,435
| -17% | -$1.23M |
|
|
CBAY
540
DELISTED
Cymabay Therapeutics
CBAY
| $8.72M | 0.02% |
2,500,000
+1,000,000
| +67% | +$2.89M |
|
541
TotalEnergies
TTE
$189B
| $8.65M | 0.02% |
+225,000
| New | +$8.33M |
|
542
Host Hotels & Resorts
HST
$17.3B
| $8.64M | 0.02% |
801,033
-13,300
| -2% | -$153K |
|
543
Carnival Corporation Ltd
CCL
$41.2B
| $8.64M | 0.02% |
526,100
+73,800
| +16% | +$1.11M |
|
544
Universal Health Services
UHS
$10.4B
| $8.57M | 0.02% |
92,259
-1,400
| -1% | -$140K |
|
545
Cactus
WHD
$5.3B
| $8.51M | 0.02% |
412,500
-234,102
| -36% | -$4.06M |
|
546
Regency Centers
REG
$14.5B
| $8.5M | 0.02% |
185,300
-3,400
| -2% | -$144K |
|
|
BDSI
547
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $8.5M | 0.02% |
1,950,000
| – | – |
|
548
ProPetro Holding
PUMP
$1.35B
| $8.38M | 0.02% |
1,630,842
-2,119,923
| -57% | -$9.77M |
|
549
Ford
F
$56.8B
| $8.35M | 0.02% |
1,373,700
-2,500,588
| -65% | -$13.8M |
|
550
Iron Mountain
IRM
$36.6B
| $8.28M | 0.02% |
317,352
-5,400
| -2% | -$136K |
|
Similar funds
Adage Capital Partners's Q2 2020 Portfolio in Review
As of Q2 2020, Adage Capital Partners held 834 positions worth $39.1B, up 17% from $33.5B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Adage Capital Partners withdrew a net $1.33B in Q2 2020, closing 110 positions and reducing 309 holdings. Its most notable exit was Allergan plc, an estimated $1.66B position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Adage Capital Partners opened a new position in Royalty Pharma worth $2.23B.
- Adage Capital Partners's largest Q2 2020 buy was Royalty Pharma: 46,015,330 shares worth $2.23B.
- Adage Capital Partners added most to Burlington in Q2 2020, an estimated $191M increase.
- Adage Capital Partners's biggest Q2 2020 reduction was Lockheed Martin, cutting an estimated $339M.
- Adage Capital Partners fully exited Allergan plc in Q2 2020, selling an estimated $1.66B.
- Adage Capital Partners's ten largest holdings make up 25% of its $39.1B portfolio in Q2 2020.
- Adage Capital Partners opened 111 new positions and closed 110 in Q2 2020.
- Adage Capital Partners's portfolio value rose 17% quarter-over-quarter to $39.1B.
Based on Adage Capital Partners's 13F filing for Q2 2020, filed 14 Aug 2020.